Skip to content

Avoiding Postinduction Hypotension: the Clinical ZERO-HYPOTENSION Proof-of-concept Study

Avoiding Postinduction Hypotension: the Clinical ZERO-HYPOTENSION Proof-of-concept Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05842759
Enrollment
120
Registered
2023-05-06
Start date
2023-03-07
Completion date
2023-08-07
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Hypotension, Hypotension on Induction

Keywords

Hypotension, Low Blood Pressure, Anesthesia Induction, Surgery

Brief summary

In this clinical proof-of-concept study, the aim is to investigate the efficacy of a hypotension avoidance strategy to prevent post-induction hypotension. Specifically, it will be investigate how much postinduction hypotension occurs when using a hypotension avoidance strategy - combining continuous intraarterial blood pressure monitoring, careful administration of anesthetic drugs, and continuous administration of norepinephrine to treat hypotension - in high-risk patients having elective non-cardiac surgery.

Detailed description

Hypotension is common in patients having non-cardiac surgery with general anesthesia and is associated with organ injury. About one third of hypotension occurs postinduction - i.e., after the induction of general anesthesia but before surgical incision. Unmodifiable risk factors for postinduction hypotension include age, male sex, and a high American Society of Anesthesiologists physical status. However, postinduction hypotension is mainly driven by modifiable factors - specifically, anesthetic drugs that cause vasodilation. Vasodilation can be effectively treated with vasopressors, e.g. norepinephrine. It is reasonable to assume that postinduction hypotension is largely avoidable by careful anesthetic and hemodynamic monitoring and management during anesthetic induction. A hypotension avoidance strategy could include continuous intraarterial blood pressure monitoring, careful administration of anesthetic drugs, and continuous administration of norepinephrine to treat hypotension. However, it remains unknown to which extent a hypotension avoidance strategy actually can avoid postinduction hypotension. Before testing the effectiveness of hypotension avoidance strategies in large-scale randomized trials it is important to investigate their efficacy. In this clinical proof-of-concept study, the aim is to investigate the efficacy of a hypotension avoidance strategy to prevent post-induction hypotension. Specifically, it will be investigate how much postinduction hypotension occurs when using a hypotension avoidance strategy - combining continuous intraarterial blood pressure monitoring, careful administration of anesthetic drugs, and continuous administration of norepinephrine to treat hypotension - in high-risk patients having elective non-cardiac surgery.

Interventions

PROCEDUREMonitoring

Continuous blood pressure monitoring

PROCEDURENorepinephrine preparation

Norepinephrine infusion will be prepared and connected to peripheral or central venous catheter (infusion will not be started)

Propofol infusion will be started only when clinical effects of opioid are noticeable: 1.5 mg/kg propofol in patients less than 55 years old and 1.0 mg/kg propofol in patients 55 years or older over 90 seconds

PROCEDUREAlarm adjustment

Lower mean arterial pressure alarm threshold will be set to 75 mmHg

PROCEDUREIntervention threshold

Lower mean arterial pressure intervention threshold will be 75 mmHg: continuous norepinephrine infusion will be started when mean arterial blood decreases below 75 mmHg

Sponsors

Universitätsklinikum Hamburg-Eppendorf
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

This is a prospective, single center, clinical interventional proof-of-concept study in 120 patients scheduled for elective major non-cardiac surgery at the University Medical Center Hamburg-Eppendorf.

Eligibility

Sex/Gender
ALL
Age
45 Years to 130 Years
Healthy volunteers
No

Inclusion criteria

* American Society of Anesthesiologists physical status classification III or higher, and in whom intraarterial blood pressure monitoring is planned for clinical indication

Exclusion criteria

* Emergency surgery * Transplant surgery * History of organ transplant * Sepsis * Pregnancy * Contraindications for the use of propofol * Rapid sequence induction

Design outcomes

Primary

MeasureTime frameDescription
Area under a MAP of 65 mmHgFirst 15 minutes of induction of general anesthesiaArea under a mean arterial pressure (MAP) of 65 mmHg within the first 15 minutes of anesthetic induction \[mmHg x min\].

Secondary

MeasureTime frameDescription
Area under thresholdFirst 15 minutes of induction of general anesthesiaArea under a MAP of 60, 50, and 40 mmHg \[mmHg x min\]
DurationFirst 15 minutes of induction of general anesthesiaDuration of MAP \<65, \<60, \<50, and \<40 mmHg \[min\]
Any HypotensionFirst 15 minutes of induction of general anesthesiaAbsolute \[n\] and relative \[%\] number of patients with any MAP measurement \<65, \<60, \<50, and \<40 mmHg
1-minute HypotensionFirst 15 minutes of induction of general anesthesiaAbsolute \[n\] and relative \[%\] number of patients with at least one 1-minute episode of a MAP \<65, \<60, \<50, and \<40 mmHg
Area above the curveFirst 15 minutes of induction of general anesthesiaArea above a MAP of 100, 110, 120, 140 mmHg \[mmHg x min\]
NorepinephrineFirst 15 minutes of induction of general anesthesiaCumulative dose of norepinephrine indexed to body weight \[μg kg-1\]

Other

MeasureTime frameDescription
Cardiac Output/Index (Exploratory Endpoint)First 15 minutes of induction of general anesthesiaDescriptive analysis including minimum value, duration under threshold, area under threshold, absolute and relative number of patients with at least one episode under threshold.
Stroke Volume/Index (Exploratory Endpoint)First 15 minutes of induction of general anesthesiaDescriptive analysis including minimum value, duration under threshold, area under threshold, absolute and relative number of patients with at least one episode under threshold.
dP/dt (Exploratory Endpoint)First 15 minutes of induction of general anesthesiaDescriptive analysis including minimum value, duration under threshold, area under threshold, absolute and relative number of patients with at least one episode under threshold.
Eadyn (Exploratory Endpoint)First 15 minutes of induction of general anesthesiaDescriptive analysis including minimum value, duration under threshold, area under threshold, absolute and relative number of patients with at least one episode under threshold.
Stroke volume variation (Exploratory Endpoint)First 15 minutes of induction of general anesthesiaDescriptive analysis including minimum value, duration under threshold, area under threshold, absolute and relative number of patients with at least one episode under threshold.
Pulse pressure variation (Exploratory Endpoint)First 15 minutes of induction of general anesthesiaDescriptive analysis including minimum value, duration under threshold, area under threshold, absolute and relative number of patients with at least one episode under threshold.
Systemic vascular resistance (Exploratory Endpoint)First 15 minutes of induction of general anesthesiaDescriptive analysis including minimum value, duration under threshold, area under threshold, absolute and relative number of patients with at least one episode under threshold.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026